CN113994208A - 子宫内膜异位症的诊断方法、疾病状态监测方法和试剂盒 - Google Patents

子宫内膜异位症的诊断方法、疾病状态监测方法和试剂盒 Download PDF

Info

Publication number
CN113994208A
CN113994208A CN202080041887.2A CN202080041887A CN113994208A CN 113994208 A CN113994208 A CN 113994208A CN 202080041887 A CN202080041887 A CN 202080041887A CN 113994208 A CN113994208 A CN 113994208A
Authority
CN
China
Prior art keywords
set forth
marker
endometriosis
abundance
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080041887.2A
Other languages
English (en)
Chinese (zh)
Inventor
小林慎太
长野光司
大森宽
垣内绫子
今野良
山海直
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Jichi Medical University
National Institutes of Biomedical Innovation Health and Nutrition
Original Assignee
Chugai Pharmaceutical Co Ltd
Jichi Medical University
National Institutes of Biomedical Innovation Health and Nutrition
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd, Jichi Medical University, National Institutes of Biomedical Innovation Health and Nutrition filed Critical Chugai Pharmaceutical Co Ltd
Publication of CN113994208A publication Critical patent/CN113994208A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7052—Fibrosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202080041887.2A 2019-04-26 2020-04-24 子宫内膜异位症的诊断方法、疾病状态监测方法和试剂盒 Pending CN113994208A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019086223 2019-04-26
JP2019-086223 2019-04-26
PCT/JP2020/017595 WO2020218465A1 (ja) 2019-04-26 2020-04-24 子宮内膜症の診断方法、病態モニタリング方法及びキット

Publications (1)

Publication Number Publication Date
CN113994208A true CN113994208A (zh) 2022-01-28

Family

ID=72942212

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080041887.2A Pending CN113994208A (zh) 2019-04-26 2020-04-24 子宫内膜异位症的诊断方法、疾病状态监测方法和试剂盒

Country Status (5)

Country Link
US (1) US20220221472A1 (https=)
EP (1) EP3961217A4 (https=)
JP (3) JP7535270B2 (https=)
CN (1) CN113994208A (https=)
WO (1) WO2020218465A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021013783A1 (en) * 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis
KR20220154725A (ko) * 2020-03-16 2022-11-22 프로테오믹스 인터내셔널 피티와이 리미티드 자궁내막증 바이오마커
CN113325183B (zh) * 2021-06-01 2022-11-15 中国医学科学院北京协和医院 一种用于鉴别诊断em/fem的试剂盒
WO2025026908A1 (en) * 2023-07-28 2025-02-06 Roche Diagnostics Gmbh Serum epha1 as biomarker for endometriosis
WO2025084848A1 (ko) * 2023-10-18 2025-04-24 주식회사 노브메타파마 Clic1을 이용한 섬유증 치료제의 스크리닝 방법
WO2025260122A1 (en) * 2024-06-19 2025-12-26 Proteomics International (Ip) Pty Ltd Biomarkers for endometriosis
GB202410764D0 (en) * 2024-07-23 2024-09-04 Univ Of Hull Diagnostic test
CN118995917A (zh) * 2024-09-30 2024-11-22 暨南大学 Ppif基因作为标志物在子宫内膜异位症诊断评估中的应用
CN121304682B (zh) * 2025-12-15 2026-03-31 西安市第一医院 基于图像处理的子宫内膜异位症病灶智能识别方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374370T1 (de) * 1999-01-25 2007-10-15 Siemens Medical Solutions Diag Verfahren zur diagnose von endometriose
EP1290218B8 (en) * 2000-02-25 2007-10-03 Siemens Medical Solutions Diagnostics Endometriosis-related markers and uses thereof
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
AU2003253440A1 (en) * 2002-08-30 2004-04-30 Japan As Represented By The President Of The University Of Tokyo Method of diagnosing ovarian endometriosis
JP5159619B2 (ja) 2005-06-22 2013-03-06 ザ・ジョンズ・ホプキンス・ユニバーシティ 卵巣癌のバイオマーカー：ｃｔａｐ３関連タンパク質
AR061571A1 (es) 2006-06-23 2008-09-03 Smithkline Beecham Corp Compuesto sal del acido toluenosulfonico de 4-{[6-cloro-3-({[(2- cloro-3-fluorofenil) amino]carbonil} amino)- 2- hidroxifenil]sulfonil] -1- piperazinacarbxilato de 1.1-dimetiletilo, composicion farmaceutica que lo comprende su uso para la fabricacion de un medicamento combinacion farmaceutica con un
US9404932B2 (en) * 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay
JP2009168646A (ja) * 2008-01-17 2009-07-30 Fuji Pharmaceutical Co Ltd 子宮内膜症に特異的なバイオマーカー
US20120315267A1 (en) 2010-02-09 2012-12-13 Glaxosmithkline Llc Novel uses
WO2012112434A1 (en) 2011-02-14 2012-08-23 Allergan, Inc. Inhibiting aberrant blood vessel formation using retargeted endopeptidases
WO2013178794A1 (en) * 2012-05-31 2013-12-05 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) A novel method for the diagnosis of endometriosis
WO2015050875A1 (en) * 2013-10-01 2015-04-09 The Regents Of The University Of California Endometriosis classifier
GB201403489D0 (en) * 2014-02-27 2014-04-16 Univ London Queen Mary Biomarkers for endometriosis
JPWO2015174544A1 (ja) 2014-05-16 2017-04-20 国立研究開発法人国立精神・神経医療研究センター 精神疾患判定マーカー
KR20170014561A (ko) * 2015-07-30 2017-02-08 한국과학기술연구원 Ｃｘｃｌ7 측정 제제를 포함하는 대장암 진단용 조성물, 키트, 및 이를 이용한 대장암 진단 방법

Also Published As

Publication number Publication date
EP3961217A4 (en) 2023-09-27
JPWO2020218465A1 (https=) 2020-10-29
JP2026065204A (ja) 2026-04-14
JP2024150669A (ja) 2024-10-23
JP7535270B2 (ja) 2024-08-16
EP3961217A1 (en) 2022-03-02
US20220221472A1 (en) 2022-07-14
WO2020218465A1 (ja) 2020-10-29

Similar Documents

Publication Publication Date Title
CN113994208A (zh) 子宫内膜异位症的诊断方法、疾病状态监测方法和试剂盒
Kasvandik et al. Uterine fluid proteins for minimally invasive assessment of endometrial receptivity
US20180106817A1 (en) Protein biomarkers and therapeutic targets for renal disorders
JP2011517939A (ja) 急性心臓同種移植拒絶反応を診断する方法
KR102185987B1 (ko) Ripk3을 포함하는 당뇨병성 신증 진단용 바이오마커 및 이의 용도
KR102547531B1 (ko) 주요 우울 장애 치료 반응성 평가용 바이오마커
EP3044594B1 (en) Identification of novel biomarkers of flares of systemic lupus erythematosus
KR20150140657A (ko) 자간전증의 진단을 위한 방법 및 조성물
WO2024196872A1 (en) Methods and compositions for diagnosis of ectopic pregnancy
EP3969912A1 (en) Endomentrial receptivity determination
CN118759189A (zh) 用于诊断宫颈癌淋巴转移的生物标记物及其应用
HK40060861A (en) Method for diagnosing endometriosis, disease state monitoring method, and kit
KR102569948B1 (ko) 암 검출 방법
KR102089032B1 (ko) 보체 성분 c8 감마를 이용한 알츠하이머병의 진단방법
US9952213B2 (en) Method for evaluating ischemic heart disease by assaying complement factor H or D
US20230045066A1 (en) Biomarkers for diagnosing breast cancer and uses thereof
CN117677715A (zh) 一种骨髓瘤生物标志物serpinf2及其应用
KR20100070776A (ko) 습관성 유산 진단용 바이오마커
KR102703606B1 (ko) 반려견의 췌장염 진단용 바이오마커
KR102943281B1 (ko) 유방암 진단용 바이오마커 및 이의 용도
KR20250104676A (ko) 자궁선근증 진단을 위한 신규한 바이오마커 및 이의 용도
WO2025253002A1 (en) Sample collection for liquid biopsy
KR20250142600A (ko) 구강편평태선의 예후 예측을 위한 신규한 바이오마커 및 이의 용도
KR20250104665A (ko) 자궁내막증 진단을 위한 신규한 바이오마커 및 이의 용도
US10502749B1 (en) Method for patient stratification and drug efficacy monitoring

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40060861

Country of ref document: HK